Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

Helping health plans
and insurers to make
a bigger impact

AccessHope closes the cancer knowledge gap with access to renowned NCI expertise

AccessHope connects employees who have been diagnosed with cancer and their community-based oncologists to renowned cancer expertise from National Cancer Institute (NCI)–Designated Comprehensive Cancer Centers to help identify the right treatment early on for the best outcomes possible.

We proudly partner with NCI centers to remotely deliver the latest cancer knowledge to the people and places who need it most.

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Read More

Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

Read More

Johns Hopkins Medicine

Kimmel Cancer Center

Read More

Northwestern Medicine

Northwestern Medicine

Read More

UT Southwestern Medical Center

Harold C. Simmons Comprehensive Cancer Center

Read More

Supporting Members

Members can request a full case review for any cancer type, providing peace of mind that their treatment plan with their community oncologist is on the right path. Members and their families also gain access to compassionate nurses who can offer information and empowerment whenever they need it. This commitment to overall support has earned this service a world-class net promoter score of 90.


Supporting Plans

AccessHope’s algorithms work in collaboration with the member’s health plan to securely send certain cancer cases to our subspecialists, who can offer advice to that plan that the treating oncologist can reference — without any action required by the member. 

Hear from a plan sponsor

AccessHope is the most impactful program I had the honor of introducing in my last plan sponsor role. I can personally vouch for AccessHope’s program as it gave me the peace of mind of knowing my treatment plan was correct. It’s a scary time and very confusing as one moment you’re totally healthy and the next you have a cancer diagnosis.

Pat Pitsch

The proof is in the
(peer-reviewed) paper

Our subspecialists provided evidence-based recommendations that had the potential to influence the treatment plan in approximately 93% of cases.1

Download the study summary


How do community oncologists react to the doctor-to-doctor conversations?

Community oncologists who participated in clinical consultation calls (CCCs) with an AccessHope expert responded positively and are appreciative of our recommendations: small studies have concluded that there is high adoption, and treating oncologists are implementing some or all of our recommendations.


How does AccessHope work in practice? What exactly do you do?

AccessHope connects members to expertise from NCI–Designated Comprehensive Cancer Centers—to provide unparalleled decision support to cancer patients’ treating physicians and health plans throughout the cancer journey.

Learn more about our suite of services.


How do you handle member privacy?

AccessHope values members’ privacy. All employee information is transmitted, used and stored securely, according to applicable HIPAA guidelines.


How do you provide expertise to members with cancer? Do they need to travel?

AccessHope services do not require members to travel, but instead provide remote access to leading-edge insights.

Meet our leaders

Meet the people who are transforming the way we fight cancer


Chief Executive Officer

As CEO, Brad drives the overall executive management and direction of AccessHope. His prior roles include CEO of SolutionHealth, Executive Vice President of Apria Healthcare Inc., Executive Vice President, Business Development, for Oxford Health Plans Inc., in addition to consulting experience taking publicly traded and privately held healthcare provider and payor organizations through high-growth stages.


Chief Operating Officer & Chief Financial Officer

Debby leads day-to-day operations including operational excellence, resource management, financial strategy, and cross-functional collaboration in support of AccessHope’s vision and culture. She brings over 30 years of experience scaling private and public companies and leading teams through periods of high growth, change, and complexity, most recently as CFO and EVP at Apria Healthcare for nearly 10 years.


Chief Growth Officer

Mark drives the growth and expansion of AccessHope services while fostering client relationships. He joined AccessHope in 2020. His prior leadership experience includes successes with BridgeHealth, HealthSmart Holdings, Inc., Aon Hewitt, Great-West Healthcare, UnitedHealthcare and more.

Sachs, M.D.

Chief Medical Officer

Dr. Todd Sachs leads AccessHope’s clinical team and oversees the remote delivery of our cancer support services. Passionate about addressing healthcare disparities and promoting value-based care, Todd is deeply dedicated to staying in the know on the newest protocols and medications in the always-advancing field of oncology.


Board certified by the American Board of Surgery and a fellow of the American College of Surgeons, Todd specializes in endocrine surgery of the thyroid and parathyroid glands. He also belongs to the California Medical Association and Los Angeles Surgical Society.


Chief Information Officer

Abhishek is responsible for the management, strategy and operations of IT infrastructure and oversees the IT Strategy and Information Security Program. His experience includes success with Johns Hopkins, City Of Hope and Johnson & Johnson.


Chief Product Officer

Joy drives product strategy and innovation to ensure cancer care—pioneered by the best and brightest—is readily accessible by all. She’s a serial entrepreneur with 20 years in healthcare, including OncoHealth, Optum, Wellcare Health Plans, and Accenture.

Alvarnas, M.D.

Chief Clinical Advisor | AccessHope; VP, Government Affairs and Senior Medical Director for Employer Strategy, Clinical Professor, Hematology/HCT | City of Hope

Dr. Alvarnas is AccessHope’s Chief Clinical Advisor with a passion for changing the healthcare system to ensure the delivery of first-class cancer care. He’s also a Clinical Professor of Hematologythe Vice President of Government Affairs, and the Senior Medical Director for Employer Strategy at City of Hope, a world-renowned independent cancer research and treatment center. For the center, he leads advocacy efforts at the federal, state, and local levels, and assists in developing, marketing, and operationalizing the clinical infrastructure and activities related to employer and payer strategies. 

Barzi, M.D., Ph.D.

Vice President, Value and Strategy and Medical Director, GI Oncology | AccessHope; Director, Employer Strategy, Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research | City of Hope

Dr. Barzi is AccessHope’s Medical Director of gastrointestinal oncology, specializing in the treatment of gastrointestinal cancers affecting the colon, rectum, pancreas, stomach, and liver. She’s passionate about improving her patients’ quality of life, believing in not just high-quality care but also “high-intensity” care.

Wong, M.D.

Vice President, Development and Integration, Clinical Strategy and Medical Director | AccessHope | Assistant Clinical Professor, Department of Medical Oncology and Therapeutics Research | City of Hope

Dr. Wong is a board-certified medical oncologist and a Medical Director at AccessHope, where she holds dual roles in teleoncology for local oncologists and their patients, and organizational strategy development. She maintains broad expertise in solid tumor oncology and advocates for integrating supportive care and quality-of-life measures into precision oncology care. For her humanity and whole-person approach, she has earned recognition among peers and patients alike. 

Nathwani, M.D.

Medical Director | AccessHope | Associate Professor, Division of Multiple Myeloma and Department of Hematology and Hematopoietic Cell Transplantation| City of Hope

Dr. Nathwani is AccessHope’s Medical Director of hematologic malignancies, transplantation, and cellular therapy. He is a multiple myeloma specialist and is also an Associate Professor in the Division of Multiple Myeloma and the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope. He has been the principal investigator at City of Hope for several high-profile clinical trials in multiple myeloma and led a study of older adults with the disease. The assessments performed by him, and his team were able to influence treatment decisions while potentially increasing the safety of myeloma therapy.


Vice President of Channel Partner Sales

Brian leads AccessHope’s channel sales across the United States with a focus on health plans, third-party administrators, and strategic collaborations. Leveraging nearly 15 years of experience in creating mutually successful partnerships and scalable growth for companies in the healthcare and benefits industry, he increases access to leading cancer expertise through AccessHope’s integrated solutions for employers of any size.

Need help?

We create innovative services that help your members navigate the sometimes overwhelming world of cancer.

Our goal is to help members benefit from leading cancer expertise for optimal results.

Contact our support team


1 West HJ, Tan YA, Barzi A, Wong D, Parsley R, Sachs T. Novel program offering remote, asynchronous subspecialist input in thoracic oncology: Early experience and insights gained during the COVID-19 pandemic [published online ahead of print December 3, 2021]. JCO Oncology Practice. doi:10.1200/OP.21.00339

UT Southwestern Medical Center Partners with AccessHope to extend nationwide access to cancer expertise 

Read the Press Release